Second Allogeneic Hematopoietic Cell Transplantation for Relapse in Adults with Acute Myeloid Leukemia: Outcomes and Prognostic Factors

Second allogeneic hematopoietic cell transplantation (HCT2) is potentially curative for adults with AML experiencing relapse after a first allograft (HCT1) but prognostic factors for outcomes are poorly characterized.

Source: Biology of Blood and Marrow Transplantation - February 1, 2024 Category: Hematology Authors: Eduardo Rodr íguez-Arbolí, Megan Othus, Corentin Orvain, Naveed Ali, Filippo Milano, Chris Davis, Ryan Basom, Domitilla Baccon, Prof. Brenda M. Sandmaier, Roland B. Walter Tags: 137 Source Type: research